en_US EN
en_US EN es_MX ES
Book Appointment

Fight COVID with mAbs

Monoclonal Antibody Treatment for COVID-19
At Home & No-Cost

Exposed or tested positive for COVID-19? You may qualify for a new monoclonal antibody therapy (mAb) that will help protect you from infection and hospitalization.

Enter your zip code to see if you qualify.

Protect Yourself

mAbs can protect people from infection, worsening disease, and potential hospitalization.

Authorized by the FDA

For emergency use for those at risk of getting more serious symptoms or with high-risk COVID factors.

Free and Easy at Home.

Covered by insurance/federal uninsured fund with no out-of-pocket cost

Treating Covid19​

Monoclonal Antibody Therapies at Home

Monoclonal antibody therapy can reduce COVID-19 symptoms, hospitalization or emergency room visits when administered as soon as possible after exposure or within 10 days of symptom onset.

70%-85% reduction in hospitalization and death in patients

80% reduction of infection among patients’ households

This is an outpatient treatment, administered either intravenously or through injections. We offer this treatment free for qualifying individuals who have tested positive or been exposed to COVID-19.

Who is Eligible?

Approximately 85% of adult Americans who are exposed or test positive qualify for this treatment.

mAbs are authorized for use for people ages 12+, who have tested positive or been exposed to COVID-19 but are not hospitalized.

What you can do

Fight Covid19 NOW

Enter your zip code to see if you qualify.

Protect Yourself​

Protect Yourself

mAbs can protect people from infection, worsening disease, and potential hospitalization.

Authorized by the FDA

Authorized by the FDA

For emergency use for those at risk of getting more serious symptoms or with high-risk COVID factors.

Free and Easy at Home.

Free and Easy at Home.

Covered by insurance/federal uninsured fund with no out-of-pocket cost
About mAbs

About Monoclonal Antibody Therapy

Administered by IV (through a vein) or by injection, these outpatient COVID treatments have been shown to reduce hospitalization or emergency room visits when received early. They have also shown to reduce viral load and reduce days of symptoms. The are three authorized monoclonal antibody therapies. They are manufactured by Regeneron, Eli Lilly or Glaxo Smith Kline.

Who Can Receive Monoclonal Antibody Therapy?

These medicines are authorized for use for people age 12 and older, who have been exposed to COVID OR have tested positive for COVID-19 and who meet other specific criteria.

For more information about these treatments, the specific criteria and potential side effects, please read the Patient Fact Sheet (Regeneron, Eli Lilly or Glaxo Smith Kline).

Testimonial

My husband had Covid and is high risk. I am high risk as well. Within minutes of filling out an online application for Monoclonal antibody treatment, we received a phone call from Mabsathome. Within a couple of hours, there was a nurse at our house administering the antibody treatment. We could not have asked for better treatment, communication and care. Thank you so much for being there for us. This is truly a lifesaving treatment with little to no side effects. My husband was feeling better the next day and recovered quickly from Covid.

Connie W

Baltimore MD

mAbs Treatment

Covid-19 Recovery in 5 Steps

Enter Zip Code

Enter your zip code to determine eligibility for this program.

Fill out Form

Fill out qualification form.

We Review

A doctor will review and recommend a course of treatment. mAbs are administered either by IV or injections.

Schedule Appointment

You will be contacted to schedule your appointment

mAbs Treatment

You’ll receive a home treatment visit. Receiving mAbs intravenously takes between 20-50 min, and injections take about 3 minutes. There is a 1 hour observation period following the treatment.

Ready to protect yourself and your loved ones?

Enter your zip code to see if you qualify.

FAQ

Frequently Asked Questions.

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful viruses like SARS-CoV-2. Monoclonal antibodies attack the virus and reduce its ability to spread through your body.
No. Vaccination remains the most powerful tool against contracting Covid-19, as well as against hospitalization and death from Covid. mAbs is a therapy that helps those who have been exposed or tested positive to Covid-19 .
Yes. Those who are exposed or test positive for COVID-19 despite vaccination are eligible to qualify to receive monoclonal antibody treatment.
Yes, though it is recommended you wait 90 days post-treatment to get vaccinated.
No. Antibodies do not contain any live virus.
mAbs have been authorized by the FDA for emergency use. Any medical infusion or injection may cause side effects, such as brief pain, bleeding, bruising, soreness, swelling, fever, chills, exhaustion, nausea, headache, and possible infection at the infusion site. In rare cases, hypersensitivity and allergic reactions may also occur during or after an antibody infusion. For this reason, trained healthcare staff will monitor you during and after treatment.
Early treatment with mAbs may prevent the disease from worsening and lessen the length of your symptoms. Additionally, it could protect your household from contracting Covid from you.

Monoclonal antibody treatment is at no cost to the patient.

Once you qualify, we’ll reach out to you to schedule treatment. Treatment will be administered by a trained professional in the comfort of your own home. You can also search for a site by going to the U.S. Department of Health and Human Services website, or by calling them at 1-877-332-6585 (for English) or 1-877-366-0310 (for Spanish).

Monoclonal antibody treatment is at no cost to the patient and is billed to insurance or the /federal uninsured fund with no out-of-pocket cost